Login | Register
Profile | Log out
logo

  • Home
  • News
  • Opinion
  • Other
    • Market Updates
    • Explainers
    • Satire
  • About
  • Contact Us
    • Contact
    • Get Covered
    • Posting Guidelines
  • Subscribe
Submit An Article

Blog

  • Home
  •  
  • Blog



  • Most Read
  • Latest Comments
  • Blog
    • News

    RBA and ASIC up the ante on blockchain project, ASX writes off millions
    Public
  • Blog
    • Satire

    Australia to close borders to Omicron Persei 8
    Public
  • Blog
    • Opinion

    The New Criterion: will the listed sanitiser stocks clean up – or clean out – investors?
    Public
  • Blog
    • Opinion

    Is this the most hated company on the ASX?
    Public
  • Blog
    Opening a new frontier in treating Parkinson’s disease
    • Review
    • November 11, 2022
  • Tremors from the FTX collapse continue to be felt as DigitalX sells off 15% Bitcoin holdings
    • Review
    • January 10, 2023
  • AUDC stablecoin gathers momentum as Novatti confirms integration with XRP Ledger
    • Review
    • June 9, 2022
  • PharmAust completes dosing first cohort for MND treatment, patients respond positively
    • Review
    • January 6, 2023
  • Is this the most hated company on the ASX?
    • Review
    • August 16, 2019

Latest Articles

  • AML3D announces stronger FY26, with positive EBITDA reported in the second half
    AML3D announces stronger FY26, with positive EBITDA reported in the second half
    • News

  • Refurbished tech gives Harris Technology a second life
    Refurbished tech gives Harris Technology a second life
    • News

  • Imagion Biosystems Advances MagSense® Phase 2 Trial
    Imagion Biosystems Advances MagSense® Phase 2 Trial
    • News

  • Acrux-developed Menopause Hormone Therapy to enter Australian market
    Acrux-developed Menopause Hormone Therapy to enter Australian market
    • News

  • Evion Expands Critical Minerals Push with Nevada Fluorspar Option
    Evion Expands Critical Minerals Push with Nevada Fluorspar Option
    • News

  • Uh oh…People: A new approach to treating Social Anxiety Disorder
    • News

    Uh oh…People: A new approach to treating Social Anxiety Disorder

    If the festive season has left you feeling depleted and ready for a solid few nights in, cemented to the couch, you’re not alone. Social interactions can be draining at the best of times for my fellow introverts, but it’s even tougher for those with Social Anxiety Disorder.  According to the Diagnostic and Statistical Manual

    Read More
    Public
  • Beer sales flowing as dive bar offers ‘one free RAT with every beer’ purchased
    • Satire

    Beer sales flowing as dive bar offers ‘one free RAT with every beer’ purchased

    Hearing news of the severe RAT shortage gripping Australia amid the surge of COVID-19 cases, one clever bar owner has seen a huge influx of business from a marketing initiative offering “one free RAT with every beer purchased”. Dismayed customers however have been left shocked upon purchase of their beer and accompanying promotion which was

    Read More
    Public
  • Season’s Greetings from the Team at The Sentiment!
    • News

    Season’s Greetings from the Team at The Sentiment!

    2021 has been an incredible year for investors that have witnessed the market recover from the onset of a global pandemic to return to its pre-COVID levels. With these investment opportunities, our small team at The Sentiment covered more ASX-listed companies and published more market updates than ever before. We’ll now be taking some time

    Read More
    Public
  • Healthia acquires 10 new allied health clinics amid end of year healthcare spending boom
    • News

    Healthia acquires 10 new allied health clinics amid end of year healthcare spending boom

    If you’re one of the 14 million Australians with private health insurance, there’s a good chance you’ll be knocking on a door owned by Healthia (ASX: HLA) to utilise your extras coverage for a new pair of glasses or orthotics before the benefits lapse at the end of 2021.  That’s because Healthia already has 292Read More
    Public
  • Crowd Media enters the Metaverse with digital real estate purchase
    • News

    Crowd Media enters the Metaverse with digital real estate purchase

    With public interest in digital worlds accelerated by the transition from Facebook to Meta and the upcoming launch of their Metaverse, artificial intelligence company Crowd Media (ASX: CM8) has given a glimpse into its plans within these digital worlds. Unlike others that are just coming to the party in the form of virtual reality tech,

    Read More
    Public
  • Why haven’t we cured cancer yet?
    • Opinion

    Why haven’t we cured cancer yet?

    As investors, we are all looking to get in on the ground floor of a fantastic stock both for returns and maybe, gloating rights to our friends. Some of the best performing stocks are in the healthcare and biotechnology sectors with industry stocks making up 7% of ASX200 companies.  With many target diseases and conditions,

    Read More
    Public
  • «
  • ‹
  • 425
  • 426
  • 427
  • 428
  • 429
  • ›
  • »

Login or register for free to access unlimited reading

Register Now!
  • News

  • Opinion

  • Satire

  • About

  • Contact Us

  • Subscribe

The content published on this website is solely for general information purposes and is not to be construed as financial advice. Should you seek financial advice you should consult with an appropriately qualified person. Opinions expressed on this site are subject to change without notice and The Sentiment who produced this content is under no obligation to keep the information current. The Sentiment, affiliated companies & associates may have a conflict of interest with companies discussed on the website due to commercial arrangements, for example they may be shareholders in the company, be engaged by them to assist in investor communications or receive commission/brokerage for funds raised.

Copyright © 2020 The Sentiment. All rights reserved.
Subscribe

Enter your email address below to subscribe to The Sentiment’s weekly newsletter, highlighting the top news, research, opinion and satire articles shaping ASX investor sentiment.

The Sentiment respects your privacy and will not spam you. View our privacy policy here.